Mar 13 |
Anika Therapeutics, Inc. 2023 Q4 - Results - Earnings Call Presentation
|
Mar 13 |
Anika Therapeutics Non-GAAP EPS of $0.05 beats by $0.28, revenue of $42.97M beats by $1.57M
|
Mar 13 |
Anika Reports Fourth Quarter and Year-End 2023 Financial Results
|
Mar 13 |
Earnings Scheduled For March 13, 2024
|
Mar 12 |
Anika Therapeutics Q4 2023 Earnings Preview
|
Feb 28 |
Sutro Biopharma, Inc. (STRO) Surges 9.5%: Is This an Indication of Further Gains?
|
Feb 27 |
Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024
|
Feb 15 |
Stoke Therapeutics, Inc. (STOK) Stock Jumps 25.5%: Will It Continue to Soar?
|
Feb 14 |
Here's Why We're Not At All Concerned With Anika Therapeutics' (NASDAQ:ANIK) Cash Burn Situation
|
Feb 13 |
Anika Highlights Its Recently Launched Integrity™ Implant System and RevoMotion™ Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products During the 2024 AAOS Annual Meeting
|